One Protocol, Two Sequences: What “No Blended Peptides” Really Means for a Student Project Briefing

Why a Multi-Sequence Protocol Does Not Become a Blended Vial

It happens at the start of almost every student project cycle. A supervisor drafts a briefing note, the protocol lists two or more peptide sequences to be run side by side or in combination, and the student reads that as a shopping list for a single vial containing everything. The assumption is understandable — the protocol presents the sequences together, so surely the supplier can supply them together. Under a “no blended peptides” policy, the answer is a clear no, and understanding why is part of the scientific training rather than an inconvenience to work around.

What the supplier is actually declining to do

Research Sciences states in its published FAQs that it does not supply blended peptides — the example given is Ipamorelin combined with CJC-1295 — and that it recommends purchasing peptides individually and combining them only within a controlled experimental design. That is a statement about what leaves the fulfilment bench, not a judgement on the research question. A blended vial would fix the ratio, the diluent volume and the co-formulation on someone else’s terms, and it would arrive with a single certificate covering a mixture rather than a clean analytical record for each sequence. All materials supplied are research-use-only and are not for human or veterinary use; they are intended for controlled laboratory and analytical work only.

What the supervisor should write into the brief

A briefing note that lists more than one sequence should say so explicitly, in plain language: each sequence is ordered as a separate catalogue line, each arrives with its own batch-level documentation, and any combination happens at the bench under the student’s own worksheet. Adding a short “materials interpretation” paragraph to the brief prevents the most common first-week error — a student ordering one item and discovering, mid-assay, that the second sequence was never in the delivery. It also forces an early decision the protocol may have left vague: are the sequences being tested as separate arms, or are they being co-applied in the same in-vitro system? Those are different experiments with different controls, and the procurement pattern should reflect the answer before any order is placed. Worth noting too that every peptide vial contains trace amounts of mannitol as an excipient — included for stability during lyophilisation, solubility and protection in storage — which matters later when two reconstituted stocks meet in one well.

Turning Two Sequences Into Two Catalogue Lines, Two CoAs and One Paper Trail

Once the brief is clear, procurement becomes straightforward bookkeeping rather than guesswork. Each sequence is its own SKU, its own vial and its own CoA. In practice this means two order lines, two certificate files, two label references and two entries in the student’s materials log — a structure that makes the write-up easier, not harder, because every result can be traced back to a specific batch document.

Documentation the student should file before the first pipette tip

Vial labels combine the SKU code and an expiry date, for example BPC10-03/27, and that reference links to the corresponding CoA. Students should photograph the label, save the CoA alongside it, and quote the reference in any query to the supplier. The homepage lists “CoAs Janoshik Analytical Reports” among its published lines, along with a “≥99% Verified Purity” headline and broader purity wording elsewhere; these are marketing figures published at the time of writing and should be reconfirmed on the live page and, more importantly, against the batch CoA that actually accompanies the delivery. The FAQs also note that restocked products may carry the same Internal Test Reference as earlier stock — an ITR links to associated sample testing reports but does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colour varies and is not an indicator of identity, analytical quality or manufacturing origin.

Ordering and delivery practicalities

Where a catalogue such as Uk peptides lists Ipamorelin 5mg and CJC-1295 (No DAC) 5mg as distinct items, that separation is exactly the structure a two-sequence protocol needs. Reconstitution solutions are supplied separately — the site carries 10ml Mixing Water and Bacteriostatic Water 10ml under both wordings — so diluent should be ordered deliberately rather than assumed. A Storage Container is also listed for organised, desiccated storage. Published fulfilment terms state that orders are dispatched the next working day via Royal Mail Tracked 24, which usually delivers the following working day as a Royal Mail estimate; delivery times vary in peak periods and no arrival date should be treated as guaranteed. Because of the specialist and perishable nature of the goods, no returns are accepted once dispatched, with refunds limited to damage, incorrect supply or quality issues under the Refunds & Returns Policy. All items remain strictly for laboratory research and are not for human or veterinary use.

Bench Practice When Two Separately Reconstituted Stocks Share an Experiment

Two sequences, two vials, two reconstitution steps. Each vial should reach ambient temperature before opening, be handled in a clean environment, and have only the amount required for the experiment removed. Diluent volume for an in-vitro stock is a calculation, not an estimate: the free reconstitution calculator on the product pages works in mg, mcg, mL and U-100 or U-50 syringe scales, with optional IU conversion where a factor is known. It is a laboratory tool for setting assay concentration only and must never be used for human or veterinary dosing, and the materials themselves carry the same restriction.

Excipient carry-over and vehicle controls

Because every vial contains trace mannitol, combining equal volumes of two reconstituted stocks in a single well doubles the excipient contribution relative to a single-sequence control. That does not invalidate the design, but it must be recorded and matched: a vehicle control containing the same combined diluent and equivalent mannitol load keeps the comparison honest. Prepare each stock separately, combine only at the point of application, and avoid pooling stocks for storage — label any combined working dilution with its preparation time and discard it at the end of the session.

Records that survive a supervisor handover

Lyophilised material is stored at −20°C or below, sealed with desiccant and protected from moisture, heat and light, with repeated freeze–thaw cycles avoided; reconstituted material is less stable and should be held at 2–8°C for short-term laboratory use only. The materials log should therefore capture, per sequence: catalogue name, SKU and label reference, CoA file location, reconstitution date, diluent and final concentration, storage location and any freeze–thaw history. When a project is handed over mid-year, that log plus the two CoAs is what allows the next student to reconstruct the experiment without repeating the briefing conversation. Purchasers remain responsible for lawful use, safe handling, storage, disposal and COSHH compliance, and for confirming that each material suits the intended in-vitro application.